India rejects AstraZeneca patent appeal Times of India Earlier this year, an Indian ruling allowed a local firm to produce a vastly cheaper copy of German pharmaceutical giant Bayer's patented drug Nexavar for liver and kidney cancer. Medical charities have expressed concern that compliance with WTO rules ... |
